Abstract: A quinazoline-based compound is represented by Formula 1 or Formula 2. The compound can effectively activate the BKCa channels, and thus may be used for preventing or treating the overactive bladder caused by inactivation or decrease in activity of the BKCa channels. The compound can be included in a pharmaceutical composition or health function food for improving urinary function.

Abstract: There is provided a binder for a secondary battery anode, in which double-bond functional groups are selectively formed in a fluorine-based polymer by using an organic catalyst, and a cross-linked structure can be formed by the double bonds through only an electrode drying process without the introduction of a heterogeneous additive.

Abstract: A nonvolatile memory (NVM) device includes a data pin, a control pin, an on-die termination (ODT) pin, and a plurality of NVM memory chips commonly connected to the data pin and the control pin. A first NVM chip among the NVM chips includes an ODT circuit. The first NVM chip determines one of an ODT write mode and an ODT read mode based on a control signal received through the control pin and an ODT signal received through the ODT pin, uses the ODT circuit to perform an ODT on the data pin during the ODT write mode, and uses the ODT circuit to perform the ODT on the control pin during the ODT read mode.

Abstract: A container is provided according to an embodiment of the present disclosure. The container may include a container part in which an accommodation space configured to accommodate contents is formed, a middle body configured to communicate with the accommodation space and coupled to the container part to surround at least a portion of the container part, an inner cover rotatably connected to the middle body to open or close the accommodation space, and an outer cover rotatably connected to the middle body to open or close the middle body.

Abstract: Disclosed is a battery cell, which includes a battery case having an accommodation portion in which an electrode assembly is mounted, and a sealing portion formed by sealing an outer periphery thereof by heat fusion; an electrode lead electrically connected to an electrode tab included in the electrode assembly and protruding out of the battery case via the sealing portion; and a lead film located at a portion corresponding to the sealing portion in at least one of an upper portion and a lower portion of the electrode lead, wherein the lead film has a dented portion recessed toward an inside of the battery case, and the dented portion is opened toward an outside of the battery case.

Abstract: The present invention relates to a drought analysis method using satellite imagery, wherein image information received from artificial satellites and ground observation data are provided to a satellite image storage and management server, and preprocessing and drought analysis algorithms are performed within the server to analyze drought conditions in the respective area.

Abstract: Disclosed herein is an apparatus and method for offloading parallel computation tasks. The apparatus inserts requests to execute multiple parallel thread groups into at least one parallel thread group queues, wherein when a preset order of priority exists the requests to execute is inserted into the at least one parallel thread group queues according to the preset order of priority, executes parallel threads of the parallel thread groups using a parallel thread group execution request entry extracted from the parallel thread group queue according to the order of priority, inserts an execution result into an execution result queue when execution of the parallel threads according to an execution sequence scheduled in execution startup routine code is terminated, and checks the execution termination state of the parallel thread groups by checking the execution result queue.

Abstract: A nonvolatile memory (NVM) device includes a data pin, a control pin, an on-die termination (ODT) pin, and a plurality of NVM memory chips commonly connected to the data pin and the control pin. A first NVM chip among the NVM chips includes an ODT circuit. The first NVM chip determines one of an ODT write mode and an ODT read mode based on a control signal received through the control pin and an ODT signal received through the ODT pin, uses the ODT circuit to perform an ODT on the data pin during the ODT write mode, and uses the ODT circuit to perform the ODT on the control pin during the ODT read mode.

Abstract: The present disclosure relates to an apparatus for manufacturing a secondary battery and a method for manufacturing a secondary battery using the same. An apparatus for manufacturing a secondary battery, which comprises a pressing part configured to press a stack, in which electrodes and separators are stacked, wherein the pressing part includes: a main pressing part configured to press an entire surface of the stack; and a sub pressing part configured to press a partial surface of the stack, wherein the partial surface is formed on an end of the stack along a longitudinal direction and includes a surface having a lower height than a height of the entire surface, and the sub pressing part presses the partial surface while moving along the longitudinal direction of the stack.

Abstract: The present disclosure provides a method and apparatus for manufacturing a secondary battery. The method includes a manufacturing a unit cell including an electrode and a separator; folding a plurality of unit cells and a separator sheet to be alternately stacked so as to manufacture an electrode assembly; correcting a height difference formed on an outer surface of the electrode assembly; and pressing the electrode assembly, wherein, in the correction step, a correction sheet is disposed on an area formed with a relatively low height with respect to the inside of the electrode assembly to correct the height difference formed on the outer surface of the electrode assembly.

Abstract: The present invention provides antisense oligonucleotides for the treatment of various T-type calcium channel ?1G subunit-related disorders, and more specifically, antisense oligonucleotides for inhibiting expression of the gene encoding Cav3.1, targeting SEQ ID NO: 1, for the treatment of various neuropsychiatric disorders, including Parkinson's disease, epilepsy, essential tremor, depression, anxiety disorders, and unconsciousness.

Abstract: A jelly-roll electrode assembly includes first and second electrodes spaced apart from each other and helically arranged in a first direction around a winding axis of a central core of the assembly. A separator overlapping portion includes a first separator positioned adjacent an inner surface of a terminal end of the second electrode and extending in a second direction opposite the first direction toward the central core, and a second separator positioned adjacent a terminal end of the first separator and extending in the second direction opposite the first direction toward the central core. A loop portion in which the first and second separators are looped about each other in the central core to extend in the first direction around the first and second electrodes such that the second separator extends in both the first and second directions within the separator overlapping portion.

Abstract: The present invention relates to a light emitting package. A light emitting package according to an embodiment of the present invention may include a body, a light emitting diode chip, and a light transmission member. The body includes a cavity open at an tipper side thereof and may be formed of a ceramic material. The light emitting diode chip is mounted in the cavity of the body and may generate and emit UV light. The light transmission member may be disposed on top of the body to cover the cavity. In addition, the light transmission member may include a light transmission layer formed of sapphire and a light loss prevention layer formed on at least one surface of the light transmission layer. The light loss prevention layer may include a lower light loss prevention layer formed on a lower surface of the light transmission layer. The light emitting diode chip and the light transmission member may be spaced apart from each other to form a space therebetween.

Abstract: Disclosed is a molecular beam epitaxy (MBE) thin film growth apparatus. The MBE thin film growth apparatus includes a growth chamber which is connected to a vacuum pump and of which an inside is maintained in an ultra-high vacuum state, a substrate manipulator which is provided inside the growth chamber and on which a substrate is mounted, a load-lock chamber which is provided outside the growth chamber and communicates with the growth chamber and in which at least one substrate, which is mounted on the substrate manipulator, for growing a thin film is located, and a substrate transfer rod that transfers the substrate from the load-lock chamber to the growth chamber or from the growth chamber to the load-lock chamber, wherein the load-lock chamber is disposed to face the substrate manipulator and disposed collinear with a substrate transfer path of the substrate transfer rod.

Abstract: Disclosed is a light emitting diode package. According to one embodiment, the light emitting diode package includes a body and a light emitting diode chip. The body includes a substrate and a sidewall formed on the substrate and may be formed with a cavity therein. The light emitting diode chip may be mounted on the substrate in the cavity of the body. The sidewall may include multiple inner side surfaces formed to surround the cavity. The inner side surfaces of the sidewall may include adjacent inner side surfaces forming an angle of 90 degrees or more therebetween. In addition, the substrate may include an insulating base, a first interconnect pattern formed on the base, a second interconnect pattern spaced apart from the first interconnect pattern, and an insulating region disposed inside the cavity to separate the first interconnect pattern from the second interconnect pattern.

Abstract: The present invention relates to an oral pharmaceutical composition comprising (i) a biologically active material conjugate in which a biological active material is conjugated with a biotin moiety, a fatty acid moiety, or a combination thereof, and (ii) an excipient, wherein the absorption rate of the biologically active material is remarkably increased, whereby conventional drugs difficult to orally administer, such as proteins or peptides, can be administered orally.